Latest news
Loading news…
Symetis
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Ecublens, Vaud, Switzerland Founded 2001 51-100 employees For Profit
Symetis is a Swiss company developing minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.
Symetis was acquired by Boston Scientific in 2017 for $435M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
20
Patents
58
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active products
- 5
- Patents granted
- 58
- Trademarks
- 4
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2001
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 28
- HQ
- Ecublens, Vaud, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Mar 30, 2017
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.1
- Trend (90d)
- -0.3
Acquisitions by Symetis
Loading columns…
0 of 0Show
Page 1 / 1
20
professional contacts at Symetis
Contact execs at Symetis →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Symetis
Loading news…
FAQs about Symetis
People who checked this page also checked these
Sectors Symetis invests & acquires in
Browse the full Acquirezy directory.